MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2021

    Community-Based Multidisciplinary Program for People with Parkinson Disease: A 2-year comparison

    S. Parveen, T. Passmore, B. Brickell, S. Jackson (Stillwater, USA)

    Objective: The current study reports outcomes from a 2 year-long community-based multidisciplinary program for individuals with Parkinson disease (PD) and their families based in Oklahoma…
  • MDS Virtual Congress 2021

    The dual cognitive syndrome in Parkinson’s disease: a resting-state functional connectivity study

    Q. Devignes, C. Bordier, R. Viard, G. Carey, L. Defebvre, A. Leentjens, R. Lopes, K. Dujardin (Lille, France)

    Objective: To assess resting-state functional connectivity modifications characterizing the frontostriatal and posterior cortical cognitive subtypes in Parkinson’s Disease (PD) Background: The dual syndrome hypothesis (Kehagia…
  • MDS Virtual Congress 2021

    Low dose trihexyphenidyl use causes cognitive dysfunction in Parkinson’s disease patients.

    L. Popil, M. Gavriliuc, A. Andrusca, O. Gavriliuc (Chisinau, Republic of Moldova)

    Objective: Evaluate cognitive performance in Parkinson's disease patients receiving a low dose of trihexyphenidyl (THP). Background: Before L-Dopa's discovery, anticholinergic drugs were among the first…
  • MDS Virtual Congress 2021

    In-vivo cholinergic basal forebrain degeneration and cognition in Parkinson’s disease: imaging results from the COPPADIS study

    MJ. Grothe, MA. Labrador-Espinosa, S. Jesús, D. Macías-García, A. Adarmes-Gómez, F. Carrillo, E. Iglesias Camacho, P. Franco-Rosado, F. Roldán Lora, JF. Martín-Rodríguez, M. Aguilar Barberá, P. Pastor, S. Escalante Arroyo, B. Solano Vila, A. Cots Foraster, J. Ruiz Martínez, F. Carrillo Padilla, M. Pueyo Morlans, I. González Aramburu, J. Infante Ceberio, J. Hernández Vara, O. de Fábregues-Boixar, T. Deus Fonticoba, B. Pascual-Sedano, J. Kulisevsky, P. Martínez-Martín, D. Santos-García, P. Mir (Seville, Spain)

    Objective: To assess associations between multimodal neuroimaging measures of cholinergic basal forebrain (CBF) integrity and cognition in a well-characterized multicentric cohort of Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Parkinson’s Disease, Cognitive Function and Health Literacy: A Problem with Shared Decision Making

    O. Kaczmarek, A. Sethi, P. Tierney, B. Bumstead, M. Buhse, E. Kravis, B. Anand, M. Zarif, M. Gudesblatt (Patchogue, USA)

    Objective: To explore the relationship between health literacy and cognitive impairment in PwPD Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder with cognitive, psychiatric…
  • MDS Virtual Congress 2021

    Gait instability and dynamic Balance Characteristics in Behavioral variant Frontotemporal dementia: A cross sectional study.

    V. Ganapathy, S R. S R, S. Bharath (Bengaluru, India)

    Objective: to explore a relationship between specific balance index and gait variability in BvFTD. Background: Gait instability in Behavioral variant frontotemporal dementia (Bv FTD) is…
  • MDS Virtual Congress 2021

    Cognitive assessment in a Greek cohort of Multiple System Atrophy patients.

    A. Bougea, C. Koros, A-M. Simitsi, N. Papagiannakis, E. Efthymiopoulou, I. Pachi, C. Chrysovitsanou, R. Antonelou, V. Constantinides, E. Kapaki, L. Stefanis (Athens, Greece)

    Objective: The aim of the present study was to assess cognitive dysfunction in a Multiple System Atrophy (MSA) cohort and possible differences between disorder subtypes…
  • MDS Virtual Congress 2021

    Cognitive reserve in non-demented patients with Parkinson’s disease might protect against amyloid burden effect on cognition

    B. Fernández-Rodríguez, R. Rodríguez-Rojas, P. Guida, C. Trompeta, D. Mata-Marín, I. Obeso-Martín, L. Vela, L. García-Cañamaque, JA. Obeso, C. Gasca-Salas (Móstoles, Spain)

    Objective: To evaluate the effect of cognitive reserve (CR) in patients with Parkinson’s disease (PD) without dementia. Background: CR concept is a principal factor explaining…
  • MDS Virtual Congress 2021

    Systematic review of cognitive subtypes derived from data driven approaches in Parkinson’s disease

    D. Pourzinal, J. Yang, R. Lawson, K. Mcmahon, G. Byrne, N. Dissanayaka (Herston, Australia)

    Objective: To consolidate the current literature pertaining to cognitive subtypes derived using data-driven methods in Parkinson’s Disease (PD). Background: Recent application of the Mild Cognitive…
  • MDS Virtual Congress 2021

    Parkinson Disease with, but not without, Cognitive Decline Reveals Advanced Brain Aging

    MC. Kuo, CL. Chen, RM. Wu, WY. Tseng (Taipei, Taiwan)

    Objective: To investigate “brain age” in Parkinson disease (PD) with and without cognitive decline, and its correlation with motor and cognitive performance. Background: Although brain…
  • « Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley